To investigate the important factors that determine the bioavailability and the antiviral activity of the diaryltriazine (DATA) and diarylpyrimidine (DAPY) non-nucleoside reverse transcriptase inhibitors (NNRTIs) of HIV-1 in animal species and humans using cell-based assays, physicochemical and computed parameters.status: publishe
The majority of the drugs currently used for the treatment of HIV infections (AIDS) belong to either...
Several drug classes are utilized in the treatment of HIV infections and AIDS, of which the non-nucl...
This article reports the design, synthesis and antiviral evaluation of a new series of non-nucleosid...
A synthesis program directed toward improving the stability of imidoyl thiourea based non-nucleoside...
The synthesis and anti-HIV-1 activity of a series of diarylpyrimidines (DAPYs) are described. Severa...
Antiviral agents: A series of CN-CH2-DAPY analogues were identified as novel non-nucleoside reverse ...
A series of novel 4,6-diarylpyrimidines (4,6-DAPY) and diarylbenzenes (DABE) compounds were synthesi...
In continuation of our efforts toward identification and optimization of novel non-nucleoside revers...
We earlier reported substantial progress in designing gp120 antagonists. Notably, we discovered that...
As a continuation of our efforts to discover and develop "me-better" drugs of DAPYs, novel diarylpyr...
The recently approved anti-AIDS drug rilpivirine (TMC278, Edurant) is a nonnucleoside inhibitor (NNR...
reverse transcriptase (NNRTIs) representing eight diverse chemotypes have been correlated with their...
This paper reports the synthesis and the antiviral properties of new diarylpyrimidine (DAPY) compoun...
The majority of the drugs currently used for the treatment of HIV infections (AIDS) belong to either...
There are at present exactly 25 compounds that have been formally approved for the treatment of retr...
The majority of the drugs currently used for the treatment of HIV infections (AIDS) belong to either...
Several drug classes are utilized in the treatment of HIV infections and AIDS, of which the non-nucl...
This article reports the design, synthesis and antiviral evaluation of a new series of non-nucleosid...
A synthesis program directed toward improving the stability of imidoyl thiourea based non-nucleoside...
The synthesis and anti-HIV-1 activity of a series of diarylpyrimidines (DAPYs) are described. Severa...
Antiviral agents: A series of CN-CH2-DAPY analogues were identified as novel non-nucleoside reverse ...
A series of novel 4,6-diarylpyrimidines (4,6-DAPY) and diarylbenzenes (DABE) compounds were synthesi...
In continuation of our efforts toward identification and optimization of novel non-nucleoside revers...
We earlier reported substantial progress in designing gp120 antagonists. Notably, we discovered that...
As a continuation of our efforts to discover and develop "me-better" drugs of DAPYs, novel diarylpyr...
The recently approved anti-AIDS drug rilpivirine (TMC278, Edurant) is a nonnucleoside inhibitor (NNR...
reverse transcriptase (NNRTIs) representing eight diverse chemotypes have been correlated with their...
This paper reports the synthesis and the antiviral properties of new diarylpyrimidine (DAPY) compoun...
The majority of the drugs currently used for the treatment of HIV infections (AIDS) belong to either...
There are at present exactly 25 compounds that have been formally approved for the treatment of retr...
The majority of the drugs currently used for the treatment of HIV infections (AIDS) belong to either...
Several drug classes are utilized in the treatment of HIV infections and AIDS, of which the non-nucl...
This article reports the design, synthesis and antiviral evaluation of a new series of non-nucleosid...